Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Healthcare
Create a narrative
Vimian Group
OM:VIMIAN Community
1
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Vimian Group
Popular
Undervalued
Overvalued
Vimian Group
WA
Analyst Price Target
Consensus Narrative from 6 Analysts
iM3 Acquisition Will Expand Presence In Veterinary Dental Space
Key Takeaways Expansion in Specialty Pharma and strategic focus on cash generation are expected to drive organic growth, enhancing revenue and margins. Acquisitions and industry trends like pet humanization could boost Vimian's growth and financial flexibility, supporting long-term success.
View narrative
SEK 47.09
FV
7.8% undervalued
intrinsic discount
15.47%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
12 days ago
author updated this narrative
Your Valuation for
VIMIAN
Vimian Group
Your Fair Value
SEK
Current Price
SEK 43.40
25.1% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-7m
667m
2015
2018
2021
2024
2025
2027
2030
Revenue €667.1m
Earnings €32.9m
Advanced
Set as Fair Value